Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

STUDY ON COUMARIN AND THEIR DERIVATIVE USED IN PHARMACY FOR THE TREATMENT OF CANCER AND THEIR OTHER THERAPEUTIC APPLICATIONS

  Authors

  Miss.Chandrakala R.Wagh,  Dr.P.B.Shamkuwar,  Mr.Pawan Malode

  Keywords

Coumarin, 7-hydroxycoumarin, warfarin, coumarin derivatives, coumarins cancer treatment.

  Abstract


: Anticancer, anticoagulant as well as various activity shows by natural coumarin due to its metabolite derivative (7-hydroxycoumarin). This review article is based upon the various aspects like pharmacological activities along with its pharmacokinetic, different sources of coumarins, biosynthesis pathway, its analysis and characterization of coumarin derivatives etc. Therefore the main target of this article is to study of various derivatives of coumarin along with its pharmacological effect of it. The release of Cyclin D1 ( this is over expressed in different types of cancer) inhibited by 7-hydroxycoumarin has been shown in recent studies that are reported in many articles, this approach gives better idea about its needs in the treatment of various types of cancer. Coumarin derivatives like Esculetin that inhibits the growth and cell cycle by blocking the G1 phase in HL-60 leukemia cell which result into block the phosphorylation of retinoblastoma protein. Flavonoids also show therapeutic action in various types of leukemia treatment and in patient with HIV disorder. Genistein is isoflavone which block the tyrosine kinase enzyme blocker that has inhibitory effects on cell growth of different types of carcinoma cell lines, due to this is the best suitable candidate for cancer treatment. These are two compound having more potent inhibitory effects on cell growth of different cancer as compared to other compound.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2107661

  Paper ID - 210517

  Page Number(s) - g143-g151

  Pubished in - Volume 9 | Issue 7 | July 2021

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Miss.Chandrakala R.Wagh,  Dr.P.B.Shamkuwar,  Mr.Pawan Malode,   "STUDY ON COUMARIN AND THEIR DERIVATIVE USED IN PHARMACY FOR THE TREATMENT OF CANCER AND THEIR OTHER THERAPEUTIC APPLICATIONS", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.9, Issue 7, pp.g143-g151, July 2021, Available at :http://www.ijcrt.org/papers/IJCRT2107661.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper June 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer